Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TeamViewer AG Investor Presentation 2022

Nov 2, 2022

430_ip_2022-11-02_479bba71-0e6f-432b-ba50-ee7ec904f5d1.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

Q3/9M 2022 Results Investor/Analyst Presentation

02 November 2022

Important Notice

This presentation as well as any information communicated in connection therewith (the "Presentation") contains information regarding TeamViewer AG (the "Company") and its subsidiaries (the Company, together with its subsidiaries, "TeamViewer"). It is provided for information purposes only and should not be relied on for any purpose and may not be redistributed, reproduced, published, or passed on to any other person or used in whole or in part for any other purpose. All stated figures are unaudited.

Forward looking statements

Certain statements in this presentation may constitute forward looking statements. These statements are based on assumptions that are believed to be reasonable at the time they are made, and are subject to significant risks and uncertainties, including, but not limited to, those risks and uncertainties described in TeamViewer's disclosures. You should not rely on these forward-looking statements as predictions of future events, and TeamViewer's actual results may differ materially and adversely from any forward-looking statements discussed in these statements due to several factors, including without limitation, risks from macroeconomic developments, external fraud, lack of innovation capabilities, inadequate data security and changes in competition levels. TeamViewer undertakes no obligation, and does not expect to publicly update, or publicly revise, any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to it or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained elsewhere in this Presentation.

Alternative performance measures

This document contains certain alternative performance measures (collectively, "APMs") including billings and Adjusted EBITDA that are not required by, or presented in accordance with, IFRS, German GAAP or any other generally accepted accounting principles. TeamViewer presents APMs because they are used by management in monitoring, evaluating and managing its business and management believes these measures provide an enhanced understanding of TeamViewer's underlying results and related trends. The definitions of the APMs may not be comparable to other similarly titled measures of other companies and have limitations as analytical tools and should, therefore, not be considered in isolation or as a substitute for analysis of TeamViewer's operating results as reported under IFRS or German GAAP. APMs such as billings and Adjusted EBITDA are not measurements of TeamViewer's performance or liquidity under IFRS or German GAAP and should not be considered as alternatives to results for the period or any other performance measures derived in accordance with IFRS, German GAAP or any other generally accepted accounting principles or as alternatives to cash flow from operating, investing or financing activities.

TeamViewer has defined each of the following APMs as follows:

Billings represent the value (net) of goods and services invoiced to customers within a specific period and which constitute a contract as defined by IFRS 15.

Adjusted EBITDA is defined as operating income (EBIT) according to IFRS, plus depreciation and amortization of tangible and intangible assets (EBITDA), adjusted for the change in deferred revenue recognized in profit or loss in the period under review and for certain business transactions (income and expenses) defined by the Management Board in agreement with the Supervisory Board. Business transactions to be adjusted relate to share-based compensation schemes and other material special items that are presented separately to show the underlying operating performance of the business.

Adjusted EBITDA margin means Adjusted EBITDA as a percentage of billings.

Operational metrics and other financial measures

This document also includes further certain operational metrics and additional financial measures for information purposes. They are not required by, or presented in accordance with IFRS, German GAAP or any other generally accepted accounting principles (collectively, "other financial measures"). TeamViewer presents these operational metrics and other financial measures for information purposes and because they are used by the management for monitoring, evaluating and managing its business. The definitions of these operational metrics and other financial metrics may not be comparable to other similarly titled measures of other companies and have limitations as analytical tools and should, therefore, not be considered in isolation or as a substitute for analysis of TeamViewer's operating results, performance or liquidity as reported under IFRS or German GAAP.

TeamViewer has defined these operational metrics and other financial measures as follows:

Levered free cash flow (FCFE) means net cash from operating activities less capital expenditure for property, plant and equipment and intangible assets (excl. M&A), payments for the capital element of lease liabilities and interest paid for borrowings and lease liabilities.

Net leverage ratio means the ratio of net financial liabilities (sum of interest-bearing loans and borrowings, current and non-current, less cash and cash equivalents) to Adjusted EBITDA (LTM).

Net retention rate or NRR is calculated as recurring billings (subscription renewals, up-selling and cross-selling activities) over the last twelve months attributable to retained subscribers (subscribers who were subscribers in the previous twelve-month period) divided by the total recurring billings from the previous twelve-month period. "Retained Billings" means recurring billings (renewals, up- and cross sell) attributable to retained subscribers who were subscribers in the previous twelve-month period. Retained billings means recurring billings (renewals, up-sell & cross-sell) attributable to retained subscribers who were also subscribers in LTM-1.

New Billings means recurring billings attributable to new subscribers.

Non-recurring Billings means all billings that do not recur such as professional services and hardware reselling.

Business Overview

Oliver Steil (CEO)

Resilient business with good Q3 results

Strong profitability and cash conversion with highly accretive EPS development

Successful cross- and upsell campaigns & pricing measures prove quality of TMV core products

APAC region with signs of turnaround; robust +13% growth across EMEA

Enterprise billings up 47% yoy and high-profile client wins paralleled by strong NRR of 113%

Increased momentum of strategic tech partnership, e.g., via joint sales events

Confirmation of FY 2022 guidance:

Billings at or around €630m, revenue of €565m-580m, adj. EBITDA margin at 45-47%

Q3 KPIs 2022 at a glance

Billings
Growth (yoy)
+15% +7% cc1
€ 144.6m
Adjusted
EBITDA
€60.1m
+42% yoy
Enterprise SMB
split
18% 82%
+ -
4pp yoy
Adjusted
EBITDA Margin
42%
+8pp yoy
Revenue
Growth (yoy)
+12%
€ 143.4m
Cash
Conversion2
105%
+1pp yoy
NRR (LTM) 103%
+7pp yoy
Basic EPS (9M) 0.23€
+112%
1At constant currencies
2 Levered free cash flow divided by (unadjusted) EBITDA

Signs of a turnaround in APAC and significant EMEA uptick

Increasing quality of customer base (LTM)

Enterprise Billings by ACV Bucket1

Q3: SMB Billings: € 117.9m (+10% | +2% cc) 9M: SMB Billings: € 355.5m (+8% | +3% cc)

Q3: Enterprise Billings: € 26.7m (+47% | +37% cc) 9M: Enterprise Billings: € 88.7m (+39% | +33% cc)

1Rounded-up

Eyewear giant Specsavers leverages TeamViewer for remote access to global retail store equipment

  • Remote support for 2,300 stores worldwide with TeamViewer Tensor
  • Remotely fixing issues with in-store PCs as well as medical devices, if necessary also leveraging TeamViewer's AR solution for enhanced support in Specsavers' UK stores
  • TeamViewer meets high requirements around security and GDPR; additional advantage: integration with Microsoft
  • Smooth store operations lead to seamless customer experience

TeamViewer helps GlobalFoundries in supplying the world with semiconductors through efficient vision picking

  • TeamViewer provides enterprise AR platform Frontline for warehouse vision picking in GlobalFoundries' "Fab1" – Europe's largest semiconductor factory
  • Eliminating printout and manual sorting saves 35 percent time in the warehouse picking process
  • Inventory accuracy has increased by one third
  • New digitalized process eliminates 100,000 sheets of paper printouts / year – a matter of cost and sustainability
  • Solution fully meets GlobalFoundries' high requirements for data protection, and occupational health and safety

New partnership with Hyundai Motor to support digital innovation in the smart factory

  • TeamViewer to provide enterprise AR platform and AI capabilities to Hyundai's smart factory in Singapore
  • Joint research and development activities around ARpowered smart factory operations, immersive digital experience for frontline workers and AI support for a future automotive factory
  • Underlining increased presence in APAC, relevant value proposition for automotive industry and TeamViewer's pioneering role in Industrial Metaverse space

Financial Overview

Michael Wilkens (CFO)

TeamViewer Group with good growth and strong profitability

Quarterly Billings (in €m) and Growth Rates (yoy) Adjusted EBITDA (in €m) and Margin (in %)

Quarterly Revenue (in €m) and Growth Rates (yoy) Adjusted (Revenue) EBITDA (in €m) and Margin (in %)1

1 Adjusted (Revenue) EBITDA = Adjusted EBITDA without adjustment for the change in deferred revenue; Adjusted (Revenue) EBITDA Margin = Adjusted (Revenue) EBITDA as a percentage of revenues

SMB with good billings improvement and higher-value customers

SMB Quarterly Billings (in €m) and Growth Rates (yoy)

1 Adjusted for discontinuation of business in Russia and Belarus (for churn since Q2 2022)

Development of Total SMB Average Selling Price (in €, LTM)

Developmentof SMB Subscribers1 (in k, eop)

Enterprise growth mainly driven by EMEA & improved pipeline conversion

Enterprise Net Retention Rate1 (LTM)

Enterprise Quarterly Billings (in €m) and Growth Rates (yoy) Development of Total Enterprise Average Selling Price (in €k, LTM)

Number of Enterprise Customers Development (eop)

1 The eligible base (LTM-1) includes billings from multi-year deals only when they are up-for renewal in the respective LTM period.

Stable Q3 recurring cost base supporting strong profitability

€m (all adjusted non-IFRS figures) Q3 2022 Q3 2021 ∆ % 9M 2022 9M 2021 ∆ %
Billings 144.6 125.8 15% 444.2 393.9 13%
Cost of sales
% of billings
(10.3)
-7.1%
(8.1)
-6.4%
28% (29.3)
-6.6%
(28.2)
-7.2%
4%
Gross profit
% Margin
134.3
92.9%
117.7
93.6%
14%
-0.7 pp
414.9
93.4%
365.6
92.8%
13%
0.6 pp
Sales
% of billings
(18.7)
-13.0%
(17.6)
-14.0%
7% (56.3)
-12.7%
(51.9)
-13.2%
9%
Marketing
% of billings
(30.7)
-21.2%
(34.5)
-27.4%
-11% (88.7)
-20.0%
(61.5)
-15.6%
44%
R&D
% of billings
(12.3)
-8.5%
(10.8)
-8.6%
14% (38.7)
-8.7%
(31.1)
-7.9%
24%
G&A
% of billings
(9.4)
-6.5%
(8.4)
-6.7%
12% (21.9)
-4.9%
(22.6)
-5.7%
-3%
Other1
% of billings
(3.1)
-2.1%
(4.2)
-3.3%
-26% (7.9)
-1.8%
(9.2)
-2.3%
-14%
Total OpEx
% of billings
(74.2)
-51.3%
(75.4)
-60.0%
-2% (213.5)
-48.1%
(176.4)
-44.8%
21%
Adjusted EBITDA 60.1 42.3 42% 201.4 189.3 6%
Adjusted EBITDA Margin 41.6% 33.6% +8pp 45.3% 48.1% -3pp

Main drivers of Q3 yoy cost development:

  • Cost of sales: in line with billings growth; Q3 2021 reclassification of €1.1m debt collection costs to G&A
  • Sales: positive effect from sales bonus capitalization, partly offset by FX
  • Marketing: lower advertisement spend
  • R&D and G&A: reduced bonus in Q3 2021
  • Other: lower bad debt expense based on higher Enterprise share

¹Incl. other income/expenses and bad debt expenses of €3.7m in Q3 2022 and €4.4m in Q3 2021 / €9.2m in 9M 2022 and €12.3m in 9M 2021

Strong profitability with highly accretive EPS development

€m Q3 2022 Q3 2021 ∆ % 9M 2022 9M 2021 ∆ %
Adjusted EBITDA 60.1 42.3 42% 201.4 189.3 6%
Change in deferred revenue (1.2) 1.9 -163% (28.8) (25.0) 15%
Adjusted (Revenue) EBITDA 58.9 44.2 33% 172.6 164.3 5%
Adjustments for non-recurring1
items
(12.9) (12.9) 0% (38.2) (50.5) -24%
EBITDA 46.0 31.4 47% 134.3 113.8 18%
D&A (13.6) (13.0) 4% (40.1) (37.7) 6%
Operating profit (EBIT) 32.4 18.3 77% 94.2 76.1 24%
Financial / FX result (3.3) (7.3) -54% (23.2) (25.6) -9%
Profit before tax (EBT) 29.0 11.0 163% 71.0 50.6 40%
Income taxes (12.5) (7.3) 71% (28.2) (29.0) -3%
Profit after tax 16.5 3.7 347% 42.9 21.6 98%
Basic number of shares outstanding2 in m 180.1 200.2 -10.0% 187.5 200.1 -6.3%
Earnings per share (EPS in € per share) 0.09 0.02 397% 0.23 0.11 112%

1IFRS 2 and other items 2without treasury shares

  • Non-recurring items in Q3 2022 include an expense of €8.7m following a jury verdict in a US patent litigation case, which was mainly offset by decreasing IFRS 2 charges relating to vested shares
  • Only slight increase in D&A
  • Higher finance income in Q3 2022 due to sale of interest rate cap, lower net FX expenses leading to decreasing financial costs
  • Lower effective tax rate in Q3 2022 mainly due to decreased nondeductable IFRS 2 charges
  • Net profit plus 347% and EPS with accretive effect due to reduced share count after completed SBB; 9M 2021 EPS plus 112% yoy

Significantly improved free cash flow

€m Q3 2022 Q3 2021 ∆ % 9M 2022 9M 2021 ∆ %
Pre-tax net cash from operating activities (IFRS) 70.6 51.9 36% 158.3 157.4 1%
Income tax paid (12.6) (10.3) 22% (34.6) (39.9) -13%
Capital expenditure (excl. M&A) (3.2) (3.7) -15% (6.8) (12.1) -44%
Lease payments (2.2) (1.0) 114% (6.3) (4.6) 35%
Unlevered Free Cash Flow (uFCF) 52.6 36.8 43% 110.7 100.8 10%
as % of adj. EBITDA 88% 87% +1pp 55% 53% +2pp
as % of EBITDA 114% 117% -3pp 82% 89% -7pp
Interest paid for borrowings and lease liabilities (4.2) (4.3) -4% (12.1) (11.1) 10%
Levered Free Cash Flow (FCFE) 48.5 32.5 49% 98.6 89.8 10%
as % of adj. EBITDA 81% 77% +4pp 49% 47% +2pp
  • Income tax paid increased due to higher tax prepayments
  • CapEx mainly relates to infrastructure invest, while most of significant investments in innovation and partnerships are expensed (in OpEx)
  • Increase in lease payments mainly due to more office locations
  • Decreasing interest cost due to debt repayment
  • High Cash Conversion of 81% in relation to the adjusted EBITDA and 105% in relation to the EBITDA.

Further built on attractive financial position

Optimized financial profile to continue our growth path

Creating a world that works better

Appendix

Enterprise and SMB KPI overview

Q3'22 Q2'22 Q1'22 Q4'21 Q3'21 Q2'21 Q1'21 Q4'20 Q3'20
SMB
Billings p.q. in €m 117.9 109.3 128.3 124.4 107.6 99.3 123.3 113.9 98.7
Billings LTM in €m 479.8 469.5 459.6 454.6 444.2 435.3 428.4 407.2 388.3
Number of subscribers1 615,650 615,531 607,834 614,262 615,584 609,942 590,146 572,240 555,175
ASP (LTM) in € 773 753 745 728 710 702 713 699 687
Enterprise
Billings p.q.
in €m
26.7 26.9 35.2 29.4 18.1 22.2 23.2 14.2 7.7
Billings LTM in €m 118.1 109.5 104.9 93.0 77.8 67.4 58.7 53.0 44.5
Number of subscribers 3,296 3,062 2,873 2,712 2,419 2,252 2,058 1,885 1,658
ASP (LTM) in € 35,826 35,775 36,519 34,279 32,162 29,938 28,540 28,139 26,851
Total
Billings p.q.
in €m
144.6 136.1 163.5 153.7 125.8 121.6 146.6 128.1 106.4
t/o retained 129.4 118.1 146.5 133.2 105.4 93.4 118.9 97.9 77.9
t/o MYD 12.0 6.7 6.1 4.6 6.1
t/o new 14.9 17.0 16.2 19.8 19.9 27.7 26.7 28.7 28.2
t/o MYD 0.5 0.4 0.7 0.6 0.5
t/o non-subscribers 0.3 1.1 0.7 0.7 0.4 0.5 1.0 1.6 0.4
Billings LTM in €m 597.9 579.1 564.5 547.6 522.0 502.7 487.1 460.3 432.8
Number of subscribers1 618,946 618,593 610,707 616,974 618,003 612,194 592,204 574,125 556,833

1 Adjusted for discontinuation of business in Russia and Belarus

Q3 2022 reconciliation from management key metrics to IFRS

Management view Change in Other non-IFRS Accounting
view
€m adjusted P&L1 deferred revenue2 D&A adjustments IFRS P&L
Billings / Revenue 144.6 (1.2) 143.4 143.4
Cost of sales (10.3) (10.3) (8.4) (6.1) (24.7)
Gross profit contribution 134.3 133.1 118.6
% of Billings / Revenue 92.9% 92.8% 82.7%
Sales (18.7) (18.7) (2.2) (2.6) (23.5)
Marketing (30.7) (30.7) (0.5) (1.0) (32.1)
R&D (12.3) (12.3) (1.8) (1.1) (15.2)
G&A (9.4) (9.4) (0.8) (2.3) (12.5)
Other3 (3.1) (3.1) 0.0 0.0 (3.1)
Adj. EBITDA 60.1 58.9
% of Billings / Revenue 41.6% 41.1%
D&A (ordinary only)4 (6.2) (6.2)
Adj. EBIT / Operating profit (EBIT) 53.9 (1.2) 52.7 -7.4⁵ (12.9) 32.4
% of Billings / Revenue 37.3% 36.8% 22.6%
D&A (total)4+5 13.6
EBITDA 46.0
% of Billings / Revenue 32.1%

Margins and percentages of billings adjusted and IFRS revenue Included change in undue billings Incl. other income/expenses and bad debt expenses of €3.7m D&A excl. amortization intangible assets from PPA Amortization intangible assets from PPA

9M 2022 reconciliation from management key metrics to IFRS

Management view Change in Other non-IFRS Accounting
view
€m adjusted P&L1 deferred revenue2 D&A adjustments IFRS P&L
Billings / Revenue 444.2 (28.8) 415.4 415.4
Cost of sales (29.3) (29.3) (25.1) (6.0) (60.4)
Gross profit contribution 414.9 386.0 355.0
% of Billings / Revenue 93.4% 92.9% 85.5%
Sales (56.3) (56.3) (5.9) (9.5) (71.7)
Marketing (88.7) (88.7) (1.3) (5.4) (95.3)
R&D (38.7) (38.7) (5.7) (5.9) (50.2)
G&A (21.9) (21.9) (2.2) (14.6) (38.7)
Other3 (7.9) (7.9) 0.0 3.1 (4.8)
Adj. EBITDA 201.4 172.6
% of Billings / Revenue 45.3% 41.5%
D&A (ordinary only)4 (17.8) (17.8)
Adj. EBIT / Operating profit (EBIT) 183.6 (28.8) 154.8 -22.3⁵ (38.2) 94.2
% of Billings / Revenue 41.3% 37.3% 22.7%
D&A (total)4+5 40.1
EBITDA 134.3
% of Billings / Revenue 32.3%

Margins and percentages of billings adjusted and IFRS revenue Included change in undue billings Incl. other income/expenses and bad debt expenses of €3.7m D&A excl. amortization intangible assets from PPA Amortization intangible assets from PPA

Non-IFRS adjustments in EBITDA

€m Q3 2022 Q3 2021 9M 2022 9M 2021
Total IFRS 2 charges (4.8) (11.0) (20.3) (40.8)
TeamViewer LTIP 0.5 1.3 (0.4) (0.3)
RSU (1.2) 0.0 (2.4) 0.0
M&A related share-based compensation (2.4) (5.4) (9.0) (19.9)
Share-based compensation by TLO (1.7) (6.8) (8.6) (20.6)
Other material items (8.1) (1.1) (17.9) (6.2)
Financing, M&A, transaction-related 0.1 (0.5) 3.6 (2.2)
ReMax (0.3) 0.0 (6.9) 0.0
Other (7.9) (0.6) (14.6) (3.9)
Valuation effects 0.0 (0.8) 0.0 (3.5)
Total (12.9) (12.9) (38.2) (50.5)
  • IFRS 2 charges decreased in Q3 2022 mainly due to
  • vested shares from M&A
  • new vesting period and vested shares for TLO portion
  • The other material items in Q3 2021 include an expense of €8.7m made following a jury verdict in a US patent litigation case

The impact of multi-year contracts on billings and revenues

Example of accounting for a new 3-year contract completed on the first day of a

given quarter (illustrative and simplified presentation)

Billings vs. revenues at quarterly level (assuming deal is signed on the first day of a quarter)

  • Billings reporting reflects the signing of a contract
  • In revenue reporting (IFRS), billings of multi-year deals are spread over the term of the contract
  • With the ongoing transition from SMB to Enterprise, more and more multi-year deals are being signed
  • As a result, revenue is becoming increasingly relevant to measure actual business momentum
  • Effect on NRR: The eligible base (LTM-1) includes billings from multi-year deals only when they are up-for renewal in the respective LTM period.

Financial Statements

Profit & Loss Statement

€ thousand Q3 2022 Q3 2021 ∆ % 9M 2022 9M 2021 ∆ %
Revenue 143,390 127,684 12% 415,368 368,845 13%
Cost
of sales
-24,744 -16,702 48% -60,402 -53,656 13%
Gross profit 118,646 110,982 7% 354,966 315,189 13%
Research and development -15,152 -14,873 2% -50,196 -44,870 12%
Marketing -32,070 -36,287 -12% -95,307 -67,589 41%
Sales -23,493 -24,570 -4% -71,750 -75,372 -5%
General and administrative -12,480 -11,932 5% -38,678 -38,478 1%
Bad debt
expenses
-3,676 -4,354 -16% -9,241 -12,306 -25%
Other income 763 127 500% 4,992 2,187 128%
Other expenses -169 -764 -78% -547 -2,627 -79%
Operating Profit 32,368 18,328 77% 94,238 76,135 24%
Finance income 2,464 -134 -1934% 2,939 399 637%
Finance costs -5,285 -4,117 28% -21,914 -13,972 57%
Foreign exchange income 8,980 5,109 76% 35,664 12,366 188%
Foreign exchange costs -9,502 -8,160 16% -39,889 -24,367 64%
Profit before tax 29,025 11,026 163% 71,038 50,562 40%
Income taxes -12,544 -7,340 71% -28,168 -28,952 -3%
Profit after tax 16,481 3,685 347% 42,871 21,610 98%
Basic number of shares issued and outstanding 180,137,497 200,159,088 187,465,171 200,053,612
Earnings per share (in € per share) 0.09 0.02 397% 0.23 0.11 112%
Diluted number of shares issued and outstanding 180,228,580 200,476,623 187,733,759 200,588,744
Diluted
earnings per share (in € per share)
0.09 0.02 397% 0.23 0.11 112%

Balance Sheet

€ thousand 30 September 2022 31 December 2021
Non-current assets
Goodwill 668,530 667,224
Intangible assets 221,930 248,159
Property, plant and equipment 53,714 45,484
Financial assets 8,333 4,848
Other assets 11,013 3,824
Deferred tax assets 1,153 496
Total non-current assets 964,672 970,035
Current assets
Trade receivables 12,615 11,560
Other assets 33,111 13,029
Tax assets 11,102 1,513
Financial assets 0 0
Cash and cash equivalents 88,973 550,533
Total current assets 145,801 576,635
Total assets 1,110,474 1,546,670

Balance Sheet (cont'd)

€ thousand 30 September 2022 31 December 2021
Equity
Issued capital 186,516 201,071
Capital reserve 229,082 394,487
(Accumulated losses)/retained earnings (233,932) (276,803)
Hedge reserve 2,014 12
Foreign currency translation reserve 5,792 1,320
Treasury share reserve (100,263) 0
Total equity attributable to shareholders of TeamViewer AG 89,209 320,087
Non
-current liabilities
Provisions 521 366
Financial liabilities 520,900 842,495
Deferred revenue 13,340 6,095
Deferred and other liabilities 1,573 2,032
Other financial liabilities 5,744 8,769
Deferred tax liabilities 32,733 29,764
Total non
-current liabilities
574,811 889,522
Current liabilities
Provisions 10,313 1,893
Financial liabilities 114,050 34,973
Trade payables 9,533 7,272
Deferred revenue 266,925 244,480
Deferred and other liabilities 41,312 41,784
Other financial liabilities 2,771 5,911
Tax liabilities 1,549 749
Total current liabilities 446,453 337,061
Total liabilities 1,021,264 1,226,583
Total equity and liabilities 1,110,474 1,546,670

Cash Flow Statement

€ thousand Q3 2022 Q3 2021 ∆ % 9M 2022 9M 2021 ∆ %
Profit before tax 29,025 11,026 163% 71,038 50,562 40%
Depreciation, amortisation and impairment of non-current assets 13,610 13,040 4% 40,103 37,661 6%
Increase/(decrease) in provisions 8,196 6 >+300% 8,575 (134) <-300%
Non-operational foreign exchange (gains)/losses (2,420) 2,901 -183% 4,363 13,739 -68%
Expenses for equity settled share-based compensation 5,296 12,235 -57% 19,865 40,464 -51%
Net financial costs 2,821 4,252 -34% 18,975 13,573 40%
Change in deferred revenue 2,482 (2,518) -199% 29,690 20,203 47%
Changes in other net working capital and other 11,553 10,939 6% (34,271) (18,632) 84%
Income taxes paid (12,588) (10,333) 22% (34,569) (39,879) -13%
Cash flows from operating activities 57,975 41,546 40% 123,770 117,558 5%
Payments for tangible and intangible assets (3,159) (3,718) -15% (6,832) (12,098) -44%
Payments for financial assets 0 0 n/a 0 0 n/a
Payments for acquisitions 0 0 n/a (1,977) (23,383) -92%
Cash flows from investing activities (3,159) (3,718) -15% (8,809) (35,481) -75%

Cash Flow Statement (cont'd)

€ thousand Q3 2022 Q3 2021 ∆ % 9M 2022 9M 2021 ∆ %
Repayments of borrowings (470,376) 0 n/a (470,376) (52,730) >+300%
Proceeds from borrowings 184,323 0 n/a 184,323 400,000 -54%
Payments for the capital element of lease liabilities (2,200) (1,027) 114% (6,260) (4,647) 35%
Interest paid for borrowings and lease liabilities (4,152) (4,310) -4% (12,128) (11,054) 10%
Purchase of treasury shares (68,930) 0 n/a (300,088) 0 n/a
Cash flows from financing activities (361,335) (5,337) >+300% (604,528) 331,569 -282%
Net change in cash and cash equivalents (306,518) 32,491 <-300% (489,567) 413,647 -218%
Net foreign exchange rate difference 10,985 4,240 159% 27,702 6,021 >+300%
Net change from cash risk provisioning 1,110 187 >+300% 305 (707) -143%
Cash and cash equivalents at beginning of period 383,396 465,572 -18% 550,533 83,531 >+300%
Cash and cash equivalents at end of period 88,973 502,491 -82% 88,973 502,491 -82%